Correlation of cyclin D1 mRNA levels with clinico-pathological parameters and clinical outcome in human breast carcinomas
Open Access
- 20 January 2000
- journal article
- research article
- Published by Wiley in International Journal of Cancer
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Cyclin D1 and human neoplasiaMolecular Pathology, 1998
- Cyclin-d1-gene amplification and expression in breast carcinoma: Relation with clinicopathologic characteristics and with retinoblastoma gene product, p53 and p21waf1 immunohistochemical expressionInternational Journal of Cancer, 1997
- Estrogen-induced Activation of Cdk4 and Cdk2 during G1-S Phase Progression Is Accompanied by Increased Cyclin D1 Expression and Decreased Cyclin-dependent Kinase Inhibitor Association with Cyclin E-Cdk2Journal of Biological Chemistry, 1997
- Clinical significance of cyclin D1 expression in patients with node-positive breast carcinoma treated with adjuvant therapyAnnals of Oncology, 1996
- Cyclin D1 and prognosis in human breast cancerInternational Journal of Cancer, 1996
- A clinicopathological study on overexpression of cyclin D1 and of p53 in a series of 248 patients with operable breast cancerBritish Journal of Cancer, 1996
- Cyclin D1-mediated inhibition of repair and replicative DNA synthesis in human fibroblasts.Genes & Development, 1994
- Dangers of Using "Optimal" Cutpoints in the Evaluation of Prognostic FactorsJNCI Journal of the National Cancer Institute, 1994
- Altered regulation of G1 cyclins in senescent human diploid fibroblasts: accumulation of inactive cyclin E-Cdk2 and cyclin D1-Cdk2 complexes.Proceedings of the National Academy of Sciences, 1993
- Histological Grading and Prognosis in Breast CancerBritish Journal of Cancer, 1957